ProCE Banner Activity

Paid Activity

CE

Hepatitis C Module #1: The abCs of HCV

Video

Pharmacists: 0.75 contact hour (0.075 CEUs)

Released: April 03, 2022

Expiration: April 03, 2023

No longer available for credit.

Course Fee

$30.00

Share

Additional Information

Program Medium

This program has been made available online.

This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.

Activity Description

Hepatitis C virus (HCV) has become one of the most common infections worldwide. According to the CDC, up to 3.9 million people in the United States may be infected. Healthcare costs associated with this disease have been climbing steadily to make it one of the costliest diseases to treat. Individuals infected with this contagious virus can remain asymptomatic for many years until HCV manifests into a serious clinical presentation. The disease can be acute or chronic ranging from mild to life threating in severity. This comprehensive four module program will provide a complete overview of HCV including disease state info, treatments, therapy selection, monitoring, and future considerations. Module One will address the epidemiology, diagnosis, and pathophysiology of HCV. Staging of HCV will also be reviewed.

Learning Objectives

The target audience for this activity includes pharmacists. Upon completion of this activity, participants will be able to:
  • Review the epidemiology and pathophysiology of hepatitis C virus (HCV)
  • Define who is at risk for HCV
  • Describe the diagnosis of HCV
  • Identify goals of HCV therapy
  • Compare methods of grading and staging liver disease

Faculty

Emily L. Heil, PharmD, BCIDP, BCPS-AQ ID
Associate Professor - Infectious Diseases
Department of Pharmacy Practice and Science
University of Maryland School of Pharmacy
Baltimore, Maryland

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Emily Heil does not have any relevant commercial and/or financial relationships to disclose.

CE Accreditation

Release Date: 04-03-2020
Expiration Date: 04-03-2023

Pharmacists

This CE activity is jointly provided by ProCE, Inc. and the National Association of Specialty Pharmacy (NASP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-208-H01-P has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 0.75 contact hour (0.075 CEU) in states that recognize ACPE providers. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Funding

No external support has been received for this activity. 
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.